GBLX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 22:08):

Stats
Dzisiejszy wolumen	81 311.00
Średni wolumen	123 712
Kapitalizacja rynkowa	2.72M
EPS	$0 ( 2024-02-02 )
Następna data zysków	( $0 ) 2024-07-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.670
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2018-07-11	Poss John C	Buy	3 615	Common Stock
2018-07-11	Poss John C	Buy	11 915	Common Stock
2018-07-11	Poss John C	Buy	20 000	Common Stock
2018-07-11	Poss John C	Buy	1 250	Common Stock
2018-07-11	Poss John C	Buy	30 000	Common Stock

INSIDER POWER
0.00
Last 84 transactions
Buy: 3 790 243 \| Sell: 13 501 701

GB Sciences, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

GB Sciences, Inc. Finanse

Annual	2022
Przychody:	$0
Zysk brutto:	$-61 660.00 (0.00 %)
EPS:	$-7 356.48

FY	2022
Przychody:	$0
Zysk brutto:	$-61 660.00 (0.00 %)
EPS:	$-7 356.48

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$0.00520

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.0133

Financial Reports:

No articles found.

GB Sciences, Inc.

GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.